RevolKa Reimagines Antibody Engineering with "RevoAb®"

AI Briefing

• – RevolKa launches RevoAb, an AI-powered antibody sequence optimization service to improve physicochemical properties and antibody yields.
• – RevoAb aims to solve challenges in antibody engineering with its innovative and quick online platform.
• – RevolKa's aiProtein technology powers RevoAb, enabling faster and more efficient antibody design.